A comparison of antiepileptic drug therapy in patients with severe intellectual disability and patients with normal intellect

Epilepsy and Behavior

Volumn 25, Issue 2, 2012, Pages 196-199

  Fridhandler, Jonathan D ^a   Coelho, Fernando M ^b,d   Tai, Peter ^d   Jette, Nathalie ^a,c   Andrade, Danielle M ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antiepileptic drugs; Clobazam; Epilepsy; Intellectual disability; Mental retardation

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; NITRAZEPAM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; EPILEPSY; FEMALE; FOCAL EPILEPSY; HUMAN; INTELLECTUAL IMPAIRMENT; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEIZURE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BENZODIAZEPINES; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; INTELLECTUAL DISABILITY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84867906692     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.07.029     Document Type: Article

References (40)

1. Kerr M.P., Mensah S., Besag F., et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011, 52:2133-2138.
2. Kerr M., Scheepers M., Arvio M., Beavis J., Brandt C., Brown S. Consensus guidelines into the management of epilepsy in adults with an intellectual disability. J Intellect Disabil Res 2009, 53:687-694.
3. Beavis J., Kerr M., Marson A.G. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev [Internet] 2007, [cited 2011 Nov 17]. Available from: http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005399/frame.html.
4. Carpay J.A., Aalbers K., Graveland G.A., Engelsman M. Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy. Seizure 2009, 18:119-123.
5. Pellock J.M., Morton L.D. Treatment of epilepsy in the multiply handicapped. Ment Retard Dev Disabil Res Rev 2000, 6:309-323.
6. Mattson R.H. The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps. Epilepsia 1996, 37:S45-S53.
7. McKee J.R., Sunder T.R., Vuong A., Hammer A. Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation. J Child Neurol 2006, 21:372-379.
8. McKee J.R., Sunder T.R., FineSmith R., et al. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation. Epilepsy Behav 2003, 4:386-394.
9. Besag F.M. Lamotrigine in the treatment of epilepsy in people with intellectual disability. J Intellect Disabil Res 1998, 42:50-56.
10. Martin P., Walter-Fränkel S. Levetiracetam in adult epilepsy patients with severe or profound mental retardation: prospective, psychometric study of tolerability. Z Epileptol 2011, 24:45-51.
11. Beavis J., Meeks A., Felce D., Kerr M. Levetiracetam in adult epilepsy patients with severe or profound mental retardation. Seizure 2009, 18:279-284.
12. Kelly K., Stephen L.J., Brodie M.J. Levetiracetam for people with mental retardation and refractory epilepsy. Epilepsy Behav 2004, 5:878-883.
13. Martin P., Schreiner A., Rettig K., Schäuble B. Topiramate in patients with epilepsy and intellectual disability. Epilepsy Behav 2009, 14:496-502.
14. Kerr M.P., Baker G.A., Brodie M.J. A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: impact on seizures, severity, and quality of life. Epilepsy Behav 2005, 7:472-480.
15. Arvio M., Sillanpää M. Topiramate in long-term treatment of epilepsy in the intellectually disabled. J Intellect Disabil Res 2005, 49:183-189.
16. Singh B.K., White-Scott S. Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities. Seizure 2002, 11:47-50.
17. Crawford P., Brown S., Kerr M. A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy. Seizure 2001, 10:107-115.
18. Mikati M.A., Choueri R., Khurana D.S., Riviello J., Helmers S., Holmes G. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability. J Intellect Disabil Res 1998, 42:57-62.
19. Modur P.N., Milteer W.E. Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsy. Epilepsy Behav 2008, 13:554-556.
20. Huber B., Bocchicchio M., Feuerbaum E., et al. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability. Epilepsy Behav 2008, 13:397-401.
21. Fejerman N., Cersosimo R., Caraballo R., et al. Vigabatrin as a first-choice drug in the treatment of West syndrome. J Child Neurol 2000, 15:161-165.
22. Ylinen A. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability. J Intellect Disabil Res 1998, 42(Suppl. 1):46-49.
23. Feucht M., Brantner-Inthaler S. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study. Epilepsia 1994, 35:993-998.
24. Kälviäinen R. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy. J Intellect Disabil Res 1998, 42:63-67.
25. Brown W.M., Aiken S.P. Felbamate: clinical and molecular aspects of a unique antiepileptic drug. Crit Rev Neurobiol 1998, 12:205-222.
26. The Felbamate Study Group in Lennox-Gastaut Syndrome Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1998, 328:29-33.
27. Sillanpää M., Pihlaja T. Oxcarbazepine (GP 47 680) in the treatment of intractable seizures. Acta Paediatr Hung 1988, 29:359-364.
28. Gaily E., Granstrom M.L., Liukkonen E. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. J Intellect Disabil Res 1998, 42(Suppl. 1):41-45.
29. Bergey G.K. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia 2005, 46(Suppl. 9):161-168.
30. Huber B., Hauser I., Horstmann V., et al. Long-term course of epilepsy in a large cohort of intellectually disabled patients. Seizure 2007, 16:35-42.
31. Tobias E.S., Brodie A.F., Brodie M.J. An outcome audit at the epilepsy clinic: results from 1000 consecutive referrals. Seizure 1994, 3:37-43.
32. Huber B., Bocchicchio M., Hauser I., et al. Ambiguous results of an attempt to withdraw barbiturates in epilepsy patients with intellectual disability. Seizure 2009, 18:109-118.
33. Arain A., Shihabuddin B., Niaz F., et al. Epilepsy and the effect of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting. Epilepsia 2006, 47:2052-2057.
34. Riss J., Cloyd J., Gates J., Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand 2008, 118:69-86.
35. Montenegro M.A., Arif H., Nahm E.A., Resor S.R., Hirsch L.J. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center. Clin Neuropharmacol 2008, 31:333-338.
36. Michael B., Marson A.G. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst Rev [Internet] 2008, [cited 2011 Nov 17]. Available from: http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004154/frame.html.
37. Kinoshita M., Ikeda A., Begum T., Terada K., Shibasaki H. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. J Neurol Sci 2007, 263:44-48.
38. Ng Y.T., Conry J.A., Drummond R., Stolle J., Weinberg M.A. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology 2011, 77:1473-1481.
39. Hosain S.A., Green N.S., Solomon G.E., Chutorian A. Nitrazepam for the treatment of Lennox-Gastaut syndrome. Pediatr Neurol 2003, 28:16-19.
40. Machado V.H., Palmini A., Bastos F.A., Rotert R. Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: a 'proof of concept', open label study. Epilepsia 2011, 52:1303-1310.